Biotechnology
The Biotechnology industry has a total of 585 stocks, with a combined market cap of $1.23 trillion and total revenue of $109.16 billion.
Market Cap
1.23T
Revenue
109.16B
Profits
-41.6B
PE Ratio
n/a
Profit Margin
-38.10%
Dividend Yield
0.04%
585 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 123.36B | 1.88% | 1,370,960 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 69.07B | 2.18% | 730,245 | 14.92B |
| 3 | ARGX | argenx SE | 53.69B | -0.57% | 205,701 | 4.74B |
| 4 | RVMD | Revolution Medicines, Inc. | 38.09B | -2.85% | 1,725,137 | - |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 37.80B | 1.44% | 1,436,414 | 4.29B |
| 6 | ONC | BeOne Medicines AG | 35.29B | 1.98% | 594,849 | 5.74B |
| 7 | RPRX | Royalty Pharma plc | 33.70B | 3.94% | 3,591,515 | 2.44B |
| 8 | MRNA | Moderna, Inc. | 25.06B | -7.51% | 5,593,101 | 2.23B |
| 9 | ROIV | Roivant Sciences Ltd. | 24.40B | -2.75% | 3,990,399 | 8.26M |
| 10 | INCY | Incyte Corporation | 23.30B | 1.36% | 1,365,126 | 5.36B |
| 11 | INSM | Insmed Incorporated | 23.29B | -2.14% | 2,754,213 | 819.56M |
| 12 | BNTX | BioNTech SE | 23.15B | -0.47% | 670,293 | 3.23B |
| 13 | GMAB | Genmab A/S | 17.76B | -0.34% | 1,568,351 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 16.14B | -3.27% | 485,853 | 998.25M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 15.74B | -2.86% | 3,529,197 | 579.96M |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 15.21B | 1.20% | 430,678 | 4.44B |
| 17 | EXEL | Exelixis, Inc. | 14.00B | 0.23% | 2,031,020 | 2.38B |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.58B | -0.86% | 238,337 | 1.13B |
| 19 | AXSM | Axsome Therapeutics, Inc. | 12.20B | -0.21% | 639,659 | 708.24M |
| 20 | ABVX | ABIVAX Société Anonyme | 11.76B | 0.61% | 1,556,937 | 5.67M |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 11.60B | 1.78% | 1,302,188 | 3.24B |
| 22 | TECH | Bio-Techne Corporation | 11.18B | 0.41% | 3,424,546 | 1.21B |
| 23 | CYTK | Cytokinetics, Incorporated | 10.91B | -2.74% | 1,406,794 | 105.82M |
| 24 | SMMT | Summit Therapeutics Inc. | 10.68B | -8.69% | 3,754,199 | - |
| 25 | KRYS | Krystal Biotech, Inc. | 10.08B | -2.41% | 270,974 | 417.30M |
| 26 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.05B | -0.62% | 2,578,673 | 622.01M |
| 27 | APGE | Apogee Therapeutics, Inc. | 10.05B | -0.16% | 1,359,089 | - |
| 28 | NUVL | Nuvalent, Inc. | 9.83B | - | 3,072,048 | - |
| 29 | CORT | Corcept Therapeutics Incorporated | 9.63B | 0.17% | 878,107 | 769.10M |
| 30 | KYMR | Kymera Therapeutics, Inc. | 9.38B | -0.11% | 713,792 | 51.48M |
| 31 | HALO | Halozyme Therapeutics, Inc. | 9.20B | 2.27% | 1,942,109 | 1.51B |
| 32 | IONS | Ionis Pharmaceuticals, Inc. | 9.03B | -0.15% | 3,805,260 | 1.06B |
| 33 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.85B | 0.01% | 3,616,056 | 18.07M |
| 34 | PRAX | Praxis Precision Medicines, Inc. | 8.59B | -3.21% | 362,654 | 7.46M |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 8.49B | -2.54% | 602,065 | 74.06M |
| 36 | SYRE | Spyre Therapeutics, Inc. | 8.28B | -7.79% | 1,370,654 | - |
| 37 | PCVX | Vaxcyte, Inc. | 8.09B | -1.23% | 1,050,243 | - |
| 38 | IMVT | Immunovant, Inc. | 8.00B | -2.31% | 967,306 | - |
| 39 | IBRX | ImmunityBio, Inc. | 7.80B | -3.62% | 7,706,336 | 140.98M |
| 40 | TGTX | TG Therapeutics, Inc. | 7.78B | -2.62% | 2,191,881 | 700.35M |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.27B | -3.28% | 615,727 | 217.17M |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 7.16B | -3.01% | 424,646 | 569.61M |
| 43 | PTCT | PTC Therapeutics, Inc. | 6.51B | -0.41% | 1,888,995 | 827.11M |
| 44 | COGT | Cogent Biosciences, Inc. | 6.48B | -3.46% | 2,576,187 | - |
| 45 | XENE | Xenon Pharmaceuticals Inc. | 6.47B | -1.08% | 1,502,103 | 7.50M |
| 46 | SRRK | Scholar Rock Holding Corporation | 6.20B | -4.27% | 1,052,481 | - |
| 47 | CGON | CG Oncology, Inc. | 6.13B | -4.79% | 1,221,693 | 5.07M |
| 48 | BLTE | Belite Bio, Inc | 5.93B | 0.80% | 116,252 | - |
| 49 | ERAS | Erasca, Inc. | 5.91B | -10.54% | 9,316,625 | - |
| 50 | LGND | Ligand Pharmaceuticals Incorporated | 5.87B | 0.06% | 241,733 | 274.48M |
| 51 | DFTX | Definium Therapeutics, Inc. | 5.85B | -3.42% | 3,460,100 | - |
| 52 | DNTH | Dianthus Therapeutics, Inc. | 5.21B | -4.56% | 1,179,946 | 1.34M |
| 53 | TVTX | Travere Therapeutics, Inc. | 5.14B | -2.57% | 1,438,096 | 536.20M |
| 54 | ORKA | Oruka Therapeutics, Inc. | 5.01B | -4.17% | 560,699 | - |
| 55 | CRSP | CRISPR Therapeutics AG | 4.78B | -5.45% | 2,101,227 | 4.10M |
| 56 | CAI | Caris Life Sciences, Inc. | 4.66B | -5.61% | 3,596,311 | 907.29M |
| 57 | MANE | Veradermics, Incorporated | 4.42B | -14.45% | 1,455,309 | - |
| 58 | LEGN | Legend Biotech Corporation | 4.39B | -1.43% | 3,082,335 | 1.14B |
| 59 | ACAD | ACADIA Pharmaceuticals Inc. | 4.39B | -1.12% | 2,189,326 | 1.10B |
| 60 | CELC | Celcuity Inc. | 4.31B | -3.52% | 3,416,798 | - |
| 61 | VKTX | Viking Therapeutics, Inc. | 4.22B | -3.81% | 1,529,156 | - |
| 62 | RLAY | Relay Therapeutics, Inc. | 4.22B | -0.72% | 3,592,458 | 10.68M |
| 63 | EWTX | Edgewise Therapeutics, Inc. | 4.11B | -6.47% | 691,843 | - |
| 64 | TNGX | Tango Therapeutics, Inc. | 4.00B | -8.63% | 3,744,718 | 56.99M |
| 65 | DYN | Dyne Therapeutics, Inc. | 3.76B | -5.29% | 1,681,835 | - |
| 66 | TLX | Telix Pharmaceuticals Limited | 3.71B | -4.07% | 64,613 | 803.79M |
| 67 | PBLS | Parabilis Medicines, Inc. | 3.70B | -2.84% | 520,601 | - |
| 68 | NAMS | NewAmsterdam Pharma Company N.V. | 3.63B | -2.91% | 1,026,612 | 22.57M |
| 69 | DNLI | Denali Therapeutics Inc. | 3.61B | -1.26% | 2,441,933 | - |
| 70 | ELVN | Enliven Therapeutics, Inc. | 3.55B | -4.33% | 867,037 | - |
| 71 | ALMS | Alumis Inc. | 3.47B | -5.48% | 1,283,293 | 8.40M |
| 72 | ARQT | Arcutis Biotherapeutics, Inc. | 3.47B | -0.14% | 1,749,961 | 415.62M |
| 73 | IDYA | IDEAYA Biosciences, Inc. | 3.42B | -2.20% | 822,866 | 225.27M |
| 74 | RCUS | Arcus Biosciences, Inc. | 3.35B | -4.93% | 1,303,354 | 236.00M |
| 75 | GPCR | Structure Therapeutics Inc. | 3.27B | -7.23% | 654,228 | - |
| 76 | RARE | Ultragenyx Pharmaceutical Inc. | 2.97B | -4.70% | 1,829,573 | 670.00M |
| 77 | BEAM | Beam Therapeutics Inc. | 2.83B | -7.94% | 4,194,498 | 164.01M |
| 78 | VERA | Vera Therapeutics, Inc. | 2.81B | -7.95% | 1,611,169 | - |
| 79 | IRON | Disc Medicine, Inc. | 2.81B | -3.35% | 513,838 | - |
| 80 | CLDX | Celldex Therapeutics, Inc. | 2.78B | -7.60% | 954,886 | 865.00K |
| 81 | MBX | MBX Biosciences, Inc. | 2.78B | -3.89% | 834,990 | - |
| 82 | QURE | uniQure N.V. | 2.71B | -4.00% | 1,257,235 | 18.09M |
| 83 | ATAI | AtaiBeckley Inc. | 2.63B | 33.40% | 166,025,291 | 3.49M |
| 84 | KOD | Kodiak Sciences Inc. | 2.58B | -2.76% | 463,811 | - |
| 85 | MESO | Mesoblast Limited | 2.52B | -2.08% | 950,706 | 65.38M |
| 86 | IMNM | Immunome, Inc. | 2.51B | -3.14% | 1,098,910 | 4.02M |
| 87 | TARS | Tarsus Pharmaceuticals, Inc. | 2.48B | 0.33% | 1,520,625 | 535.08M |
| 88 | TRVI | Trevi Therapeutics, Inc. | 2.46B | -4.35% | 3,119,650 | - |
| 89 | VCEL | Vericel Corporation | 2.44B | 2.33% | 406,309 | 292.09M |
| 90 | NRIX | Nurix Therapeutics, Inc. | 2.39B | -3.27% | 861,770 | 36.77M |
| 91 | MLYS | Mineralys Therapeutics, Inc. | 2.39B | -0.84% | 782,727 | - |
| 92 | KLRA | Kailera Therapeutics, Inc. | 2.37B | -5.08% | 397,853 | - |
| 93 | PHVS | Pharvaris N.V. | 2.35B | -4.27% | 289,265 | - |
| 94 | ZLAB | Zai Lab Limited | 2.33B | 1.52% | 654,373 | 453.28M |
| 95 | SLS | SELLAS Life Sciences Group, Inc. | 2.31B | -8.13% | 8,992,425 | - |
| 96 | AGIO | Agios Pharmaceuticals, Inc. | 2.30B | -2.88% | 726,960 | 66.05M |
| 97 | NKTR | Nektar Therapeutics | 2.27B | -1.83% | 746,227 | 55.63M |
| 98 | BHVN | Biohaven Ltd. | 2.13B | -4.64% | 1,406,359 | - |
| 99 | PVLA | Palvella Therapeutics, Inc. | 2.12B | -2.76% | 271,643 | - |
| 100 | IOVA | Iovance Biotherapeutics, Inc. | 2.08B | -1.69% | 28,210,344 | 285.61M |
| 101 | COAG | Hemab Therapeutics Holdings, Inc. | 2.08B | 2.79% | 394,040 | - |
| 102 | AUPH | Aurinia Pharmaceuticals Inc. | 2.05B | -0.99% | 830,149 | 298.30M |
| 103 | SION | Sionna Therapeutics, Inc. | 2.04B | 2.05% | 1,096,320 | - |
| 104 | ADMA | ADMA Biologics, Inc. | 2.04B | 1.50% | 2,805,667 | 509.86M |
| 105 | SNDX | Syndax Pharmaceuticals, Inc. | 2.01B | -3.44% | 1,597,274 | 217.17M |
| 106 | OCUL | Ocular Therapeutix, Inc. | 2.01B | -7.98% | 2,719,495 | 52.04M |
| 107 | GHRS | GH Research PLC | 2.00B | 8.21% | 1,483,485 | - |
| 108 | VRDN | Viridian Therapeutics, Inc. | 1.99B | -5.40% | 2,097,592 | 70.92M |
| 109 | NUVB | Nuvation Bio Inc. | 1.96B | -4.41% | 4,011,146 | 143.05M |
| 110 | LKFT | Lakefront Biotherapeutics NV | 1.96B | 0.41% | 200,611 | 1.20B |
| 111 | GLUE | Monte Rosa Therapeutics, Inc. | 1.96B | -1.07% | 1,149,616 | 42.95M |
| 112 | URGN | UroGen Pharma Ltd. | 1.95B | 0.50% | 1,241,265 | 140.49M |
| 113 | NBTX | Nanobiotix S.A. | 1.94B | -6.08% | 144,568 | 38.27M |
| 114 | HRMY | Harmony Biosciences Holdings, Inc. | 1.94B | -3.93% | 1,614,401 | 899.11M |
| 115 | RAPP | Rapport Therapeutics, Inc. | 1.92B | 0.50% | 350,671 | 20.00M |
| 116 | TSHA | Taysha Gene Therapies, Inc. | 1.91B | -3.55% | 4,158,228 | 7.47M |
| 117 | ABCL | AbCellera Biologics Inc. | 1.88B | -8.61% | 7,547,837 | 79.21M |
| 118 | TYRA | Tyra Biosciences, Inc. | 1.88B | -2.38% | 473,667 | - |
| 119 | KARD | Kardigan, Inc. | 1.88B | -4.41% | 378,169 | - |
| 120 | DMRA | Damora Therapeutics, Inc. | 1.86B | -2.29% | 356,045 | - |
| 121 | AAPG | Ascentage Pharma Group International | 1.85B | 1.09% | 2,027 | 82.08M |
| 122 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.83B | 0.71% | 5,237,987 | 204.73M |
| 123 | SRPT | Sarepta Therapeutics, Inc. | 1.82B | -2.16% | 3,180,760 | 2.18B |
| 124 | BCAX | Bicara Therapeutics Inc. | 1.81B | -1.85% | 445,093 | - |
| 125 | STOK | Stoke Therapeutics, Inc. | 1.81B | -2.67% | 555,053 | 32.08M |
| 126 | ZBIO | Zenas BioPharma, Inc. | 1.78B | -3.98% | 884,134 | 10.00M |
| 127 | PGEN | Precigen, Inc. | 1.76B | -3.32% | 3,943,713 | 31.60M |
| 128 | IMCR | Immunocore Holdings plc | 1.75B | -0.61% | 762,534 | 412.81M |
| 129 | GENB | Generate Biomedicines, Inc. | 1.75B | -2.91% | 393,235 | 30.30M |
| 130 | ZYME | Zymeworks Inc. | 1.73B | -1.91% | 458,798 | 81.26M |
| 131 | FTRE | Fortrea Holdings Inc. | 1.70B | 0.06% | 1,682,932 | 2.71B |
| 132 | MPLT | MapLight Therapeutics, Inc. | 1.69B | -0.29% | 985,435 | - |
| 133 | NTLA | Intellia Therapeutics, Inc. | 1.66B | -9.05% | 6,531,742 | 66.09M |
| 134 | INVA | Innoviva, Inc. | 1.64B | 1.46% | 644,095 | 420.69M |
| 135 | ANAB | AnaptysBio, Inc. | 1.60B | -2.99% | 866,367 | 232.39M |
| 136 | RXRX | Recursion Pharmaceuticals, Inc. | 1.60B | -8.76% | 40,174,579 | 66.41M |
| 137 | VIR | Vir Biotechnology, Inc. | 1.59B | -2.19% | 1,955,117 | 65.50M |
| 138 | MLTX | MoonLake Immunotherapeutics | 1.57B | -4.76% | 1,422,043 | - |
| 139 | AVBP | ArriVent BioPharma, Inc. | 1.53B | -0.58% | 473,128 | - |
| 140 | MAZE | Maze Therapeutics, Inc. | 1.50B | -7.57% | 819,671 | 20.00M |
| 141 | SEPN | Septerna, Inc. | 1.42B | -7.37% | 416,730 | 72.26M |
| 142 | SVRA | Savara Inc. | 1.40B | -4.99% | 1,218,698 | - |
| 143 | ABSI | Absci Corporation | 1.39B | -15.68% | 7,431,764 | 1.84M |
| 144 | AKTS | Aktis Oncology, Inc. | 1.38B | -3.77% | 314,258 | 8.28M |
| 145 | NVAX | Novavax, Inc. | 1.35B | -2.25% | 2,403,349 | 596.34M |
| 146 | INBX | Inhibrx Biosciences, Inc. | 1.31B | -2.36% | 289,092 | 1.30M |
| 147 | IMTX | Immatics N.V. | 1.28B | -0.74% | 343,292 | 43.00M |
| 148 | ARDX | Ardelyx, Inc. | 1.27B | -3.30% | 2,445,574 | 427.68M |
| 149 | TRAX | First Tracks Biotherapeutics, Inc. | 1.26B | 0.22% | 712,111 | - |
| 150 | MNKD | MannKind Corporation | 1.25B | -1.22% | 3,299,606 | 360.78M |
| 151 | JBIO | Jade Biosciences, Inc. | 1.22B | -6.31% | 1,285,004 | - |
| 152 | CRVS | Corvus Pharmaceuticals, Inc. | 1.20B | -4.36% | 1,257,063 | - |
| 153 | MGTX | MeiraGTx Holdings plc | 1.14B | -1.83% | 563,367 | 79.76M |
| 154 | AVLN | Avalyn Pharma Inc. | 1.14B | -6.28% | 289,728 | - |
| 155 | ORIC | ORIC Pharmaceuticals, Inc. | 1.11B | -3.68% | 1,261,308 | - |
| 156 | XNCR | Xencor, Inc. | 1.11B | -0.20% | 636,627 | 97.36M |
| 157 | CAPR | Capricor Therapeutics, Inc. | 1.11B | -6.04% | 1,489,709 | 11.13M |
| 158 | FBRX | Forte Biosciences, Inc. | 1.10B | 1.90% | 786,157 | - |
| 159 | EYPT | EyePoint, Inc. | 1.09B | -5.85% | 1,551,216 | 7.61M |
| 160 | WVE | Wave Life Sciences Ltd. | 1.09B | -4.06% | 2,461,817 | 71.80M |
| 161 | DRTS | Alpha Tau Medical Ltd. | 1.07B | -4.65% | 783,884 | - |
| 162 | ANRO | Alto Neuroscience, Inc. | 1.06B | -1.76% | 545,907 | - |
| 163 | SPTX | Seaport Therapeutics, Inc. | 1.04B | -4.55% | 96,877 | - |
| 164 | IVA | Inventiva S.A. | 1.03B | 1.12% | 869,738 | 7.94M |
| 165 | CGEM | Cullinan Therapeutics, Inc. | 1.01B | -7.96% | 842,967 | - |
| 166 | LXRX | Lexicon Pharmaceuticals, Inc. | 995.00M | 1.82% | 2,736,852 | 69.64M |
| 167 | OLMA | Olema Pharmaceuticals, Inc. | 966.94M | -6.35% | 1,176,137 | - |
| 168 | KURA | Kura Oncology, Inc. | 966.75M | -3.88% | 939,033 | 71.64M |
| 169 | JANX | Janux Therapeutics, Inc. | 965.99M | -1.19% | 648,091 | 13.73M |
| 170 | ANNX | Annexon, Inc. | 965.03M | -9.38% | 7,711,289 | - |
| 171 | SANA | Sana Biotechnology, Inc. | 950.68M | -10.70% | 3,678,477 | - |
| 172 | DBVT | DBV Technologies S.A. | 949.26M | -5.41% | 379,100 | 4.97M |
| 173 | AVTX | Avalo Therapeutics, Inc. | 939.87M | -3.61% | 1,269,534 | 59.00K |
| 174 | VOR | Vor Biopharma Inc. | 939.58M | -4.09% | 849,887 | - |
| 175 | ABUS | Arbutus Biopharma Corporation | 936.33M | 3.95% | 2,895,968 | 191.45M |
| 176 | PHAR | Pharming Group N.V. | 936.04M | -0.82% | 4,242 | 369.49M |
| 177 | GERN | Geron Corporation | 910.96M | - | 6,800,694 | 196.12M |
| 178 | SLDB | Solid Biosciences Inc. | 890.97M | -5.93% | 1,014,839 | - |
| 179 | TBPH | Theravance Biopharma, Inc. | 879.53M | 0.24% | 317,516 | 109.78M |
| 180 | LBRX | LB Pharmaceuticals Inc | 877.22M | -4.88% | 186,603 | - |
| 181 | PHAT | Phathom Pharmaceuticals, Inc. | 871.35M | -0.72% | 437,910 | 204.89M |
| 182 | ODTX | Odyssey Therapeutics, Inc. | 816.80M | -1.10% | 986,755 | 1.06M |
| 183 | REPL | Replimune Group, Inc. | 799.16M | -1.65% | 3,563,238 | - |
| 184 | CTMX | CytomX Therapeutics, Inc. | 797.88M | -0.41% | 4,781,871 | 35.54M |
| 185 | DSGN | Design Therapeutics, Inc. | 787.58M | -6.73% | 900,806 | - |
| 186 | RIGL | Rigel Pharmaceuticals, Inc. | 770.98M | 1.19% | 351,629 | 299.77M |
| 187 | TENX | Tenax Therapeutics, Inc. | 770.46M | -1.69% | 925,812 | - |
| 188 | OCS | Oculis Holding AG | 761.49M | -3.89% | 296,580 | 1.40M |
| 189 | AURA | Aura Biosciences, Inc. | 759.96M | -1.71% | 339,591 | - |
| 190 | ZVRA | Zevra Therapeutics, Inc. | 754.31M | -1.54% | 1,084,258 | 122.29M |
| 191 | ACRS | Aclaris Therapeutics, Inc. | 748.60M | -4.29% | 2,096,257 | 8.37M |
| 192 | SPRY | ARS Pharmaceuticals, Inc. | 740.80M | -1.19% | 1,288,298 | 98.99M |
| 193 | DRUG | Bright Minds Biosciences Inc. | 729.17M | -2.23% | 329,656 | - |
| 194 | NGNE | Neurogene Inc. | 727.33M | -7.48% | 163,515 | 925.00K |
| 195 | MNPR | Monopar Therapeutics Inc. | 726.95M | -0.16% | 193,675 | - |
| 196 | CLYM | Climb Bio, Inc. | 720.34M | -9.30% | 1,507,689 | - |
| 197 | IMMX | Immix Biopharma, Inc. | 716.17M | -4.46% | 1,502,166 | - |
| 198 | GYRE | Gyre Therapeutics, Inc. | 715.76M | -2.13% | 33,723 | 117.05M |
| 199 | SLBT | SL Science Holding Limited | 699.84M | 2.12% | 41,510 | - |
| 200 | CADL | Candel Therapeutics, Inc. | 694.60M | -1.66% | 994,707 | - |
| 201 | SGP | SpyGlass Pharma, Inc. | 694.08M | 0.78% | 159,609 | - |
| 202 | FTH | Faeth Therapeutics, Inc. | 668.70M | -17.57% | 662,910 | - |
| 203 | OMER | Omeros Corporation | 667.30M | -11.09% | 2,197,673 | 9.89M |
| 204 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 665.69M | -1.19% | 347,278 | - |
| 205 | MDXG | MiMedx Group, Inc. | 659.83M | 3.75% | 940,566 | 389.42M |
| 206 | CRMD | CorMedix Inc. | 650.37M | -1.54% | 874,705 | 400.05M |
| 207 | ALLO | Allogene Therapeutics, Inc. | 617.83M | -5.79% | 6,300,099 | 22.00K |
| 208 | ACHV | Achieve Life Sciences, Inc. | 611.85M | -5.85% | 1,765,504 | - |
| 209 | AGMB | AgomAb Therapeutics NV | 606.74M | -2.45% | 66,383 | - |
| 210 | NVCT | Nuvectis Pharma, Inc. | 586.37M | -5.05% | 341,438 | - |
| 211 | PRME | Prime Medicine, Inc. | 581.59M | -7.74% | 3,678,781 | 4.03M |
| 212 | RGNX | REGENXBIO Inc. | 579.03M | -8.72% | 2,007,778 | 87.82M |
| 213 | TECX | Tectonic Therapeutic, Inc. | 578.34M | -5.69% | 162,808 | - |
| 214 | RLMD | Relmada Therapeutics, Inc. | 572.70M | -12.08% | 1,874,451 | - |
| 215 | FDMT | 4D Molecular Therapeutics, Inc. | 566.67M | -7.19% | 893,766 | 88.24M |
| 216 | ALT | Altimmune, Inc. | 554.25M | -4.36% | 2,995,414 | 36.00K |
| 217 | STTK | Shattuck Labs, Inc. | 542.13M | 4.43% | 2,105,068 | 1.00M |
| 218 | DNA | Ginkgo Bioworks Holdings, Inc. | 541.54M | -7.89% | 1,244,286 | 151.40M |
| 219 | EIKN | Eikon Therapeutics, Inc. | 538.68M | 1.12% | 365,010 | - |
| 220 | CTNM | Contineum Therapeutics, Inc. | 523.78M | -4.24% | 237,022 | - |
| 221 | ARVN | Arvinas, Inc. | 518.11M | -3.02% | 634,532 | 89.40M |
| 222 | SLN | Silence Therapeutics plc | 515.79M | 4.50% | 567,829 | 839.00K |
| 223 | ASMB | Assembly Biosciences, Inc. | 512.08M | -3.33% | 309,430 | 71.10M |
| 224 | VSTM | Verastem, Inc. | 507.03M | 0.70% | 1,985,572 | 49.59M |
| 225 | CBIO | Crescent Biopharma, Inc. | 502.09M | -3.57% | 857,483 | 11.88M |
| 226 | ZURA | Zura Bio Limited | 498.74M | -2.60% | 789,475 | - |
| 227 | PROK | ProKidney Corp. | 486.32M | 0.63% | 1,136,422 | 889.00K |
| 228 | VALN | Valneva SE | 474.71M | -0.97% | 78,668 | 180.25M |
| 229 | SGMT | Sagimet Biosciences Inc. | 472.40M | -4.26% | 835,919 | - |
| 230 | OCGN | Ocugen, Inc. | 463.77M | -4.20% | 5,003,426 | 4.47M |
| 231 | OVID | Ovid Therapeutics Inc. | 457.27M | -1.61% | 1,515,103 | 7.12M |
| 232 | RZLT | Rezolute, Inc. | 456.52M | -7.81% | 1,072,542 | - |
| 233 | ANL | Adlai Nortye Ltd. | 454.00M | 6.77% | 335,056 | 5.00M |
| 234 | KYTX | Kyverna Therapeutics, Inc. | 452.32M | -4.37% | 1,732,449 | - |
| 235 | PRTA | Prothena Corporation plc | 443.43M | 0.47% | 659,663 | 57.94M |
| 236 | EDIT | Editas Medicine, Inc. | 441.97M | -5.26% | 1,385,737 | 38.69M |
| 237 | ARTV | Artiva Biotherapeutics, Inc. | 439.24M | -8.87% | 626,138 | 251.00K |
| 238 | HELP | Cybin Inc. | 436.37M | 8.14% | 3,780,989 | - |
| 239 | CABA | Cabaletta Bio, Inc. | 435.36M | -3.61% | 2,675,385 | - |
| 240 | BNTC | Benitec Biopharma Inc. | 434.93M | -2.76% | 48,118 | - |
| 241 | PBYI | Puma Biotechnology, Inc. | 427.56M | -0.12% | 400,225 | 227.18M |
| 242 | EVMN | Evommune, Inc. | 421.78M | -5.94% | 646,027 | 10.00M |
| 243 | PRLD | Prelude Therapeutics Incorporated | 414.56M | -6.28% | 405,790 | 16.72M |
| 244 | IPSC | Century Therapeutics, Inc. | 407.60M | 4.15% | 1,073,909 | 109.16M |
| 245 | EPRX | Eupraxia Pharmaceuticals Inc. | 403.90M | -5.52% | 165,950 | - |
| 246 | VTVT | vTv Therapeutics Inc. | 400.70M | -1.22% | 114,251 | 36.84M |
| 247 | ABEO | Abeona Therapeutics Inc. | 400.11M | -3.70% | 1,110,184 | 14.54M |
| 248 | CCCC | C4 Therapeutics, Inc. | 395.83M | -5.79% | 3,865,582 | 34.86M |
| 249 | UPB | Upstream Bio, Inc. | 393.46M | -0.55% | 561,160 | 3.32M |
| 250 | STRO | Sutro Biopharma, Inc. | 393.22M | -8.73% | 297,538 | 99.61M |
| 251 | AUTL | Autolus Therapeutics plc | 388.57M | -3.31% | 1,112,732 | 92.62M |
| 252 | DMAC | DiaMedica Therapeutics Inc. | 384.19M | -6.68% | 260,030 | - |
| 253 | ENTA | Enanta Pharmaceuticals, Inc. | 383.54M | -0.30% | 160,367 | 69.21M |
| 254 | LRMR | Larimar Therapeutics, Inc. | 383.09M | -3.67% | 1,336,206 | - |
| 255 | CMPX | Compass Therapeutics, Inc. | 378.18M | -1.87% | 1,760,206 | 850.00K |
| 256 | AVIR | Atea Pharmaceuticals, Inc. | 377.33M | -2.98% | 209,163 | - |
| 257 | RCKT | Rocket Pharmaceuticals, Inc. | 372.35M | -6.58% | 1,411,069 | - |
| 258 | FENC | Fennec Pharmaceuticals Inc. | 362.65M | -1.51% | 91,265 | 51.00M |
| 259 | XFOR | X4 Pharmaceuticals, Inc. | 361.24M | -1.79% | 504,453 | 9.01M |
| 260 | LXEO | Lexeo Therapeutics, Inc. | 358.06M | -3.80% | 780,227 | - |
| 261 | IKT | Inhibikase Therapeutics, Inc. | 342.55M | -2.43% | 584,116 | 1.00 |
| 262 | VCRE | Vicore Pharma Holding AB (publ) | 334.66M | -5.49% | 7,541 | 370.61K |
| 263 | PALI | Palisade Bio, Inc. | 328.07M | -6.90% | 1,778,654 | - |
| 264 | VNDA | Vanda Pharmaceuticals Inc. | 327.74M | -6.84% | 1,139,403 | 217.78M |
| 265 | ZNTL | Zentalis Pharmaceuticals, Inc. | 325.32M | -4.39% | 568,281 | 26.87M |
| 266 | LYEL | Lyell Immunopharma, Inc. | 324.11M | -2.59% | 140,919 | 31.00K |
| 267 | FATE | Fate Therapeutics, Inc. | 318.21M | -8.70% | 5,195,747 | 6.32M |
| 268 | IMRX | Immuneering Corporation | 309.25M | -7.36% | 1,279,980 | - |
| 269 | FHTX | Foghorn Therapeutics Inc. | 297.68M | -6.97% | 294,474 | 28.22M |
| 270 | ELDN | Eledon Pharmaceuticals, Inc. | 296.84M | -4.48% | 758,625 | - |
| 271 | NMRA | Neumora Therapeutics, Inc. | 296.45M | -1.84% | 632,040 | - |
| 272 | OABI | OmniAb, Inc. | 295.74M | -1.92% | 356,125 | 28.94M |
| 273 | BCYC | Bicycle Therapeutics plc | 291.81M | -0.95% | 293,407 | 63.50M |
| 274 | LCTX | Lineage Cell Therapeutics, Inc. | 291.68M | -4.10% | 1,154,202 | 14.78M |
| 275 | INDP | Indaptus Therapeutics, Inc. | 286.50M | -10.28% | 36,842 | - |
| 276 | IFRX | InflaRx N.V. | 281.33M | -5.45% | 715,912 | 33.82K |
| 277 | CNXU | Conexeu Sciences Inc. | 281.23M | -5.99% | 124,729 | - |
| 278 | SABS | SAB Biotherapeutics, Inc. | 280.24M | 1.24% | 521,435 | 114.70K |
| 279 | GLSI | Greenwich LifeSciences, Inc. | 279.03M | -2.71% | 201,337 | - |
| 280 | ALXO | ALX Oncology Holdings Inc. | 278.55M | 1.97% | 791,879 | - |
| 281 | GALT | Galectin Therapeutics Inc. | 278.25M | -11.24% | 556,462 | - |
| 282 | NAGE | Niagen Bioscience, Inc. | 271.36M | -2.02% | 790,147 | 130.42M |
| 283 | IRD | Opus Genetics, Inc. | 270.82M | -5.75% | 1,110,044 | 11.98M |
| 284 | TTRX | Turn Therapeutics Inc. | 268.99M | -5.74% | 88,922 | - |
| 285 | MGNX | MacroGenics, Inc. | 261.88M | -4.63% | 898,794 | 157.08M |
| 286 | QTTB | Q32 Bio Inc. | 257.91M | -3.12% | 2,345,095 | 53.74M |
| 287 | SLGL | Sol-Gel Technologies Ltd. | 255.24M | 1.11% | 101,922 | 18.47M |
| 288 | TRDA | Entrada Therapeutics, Inc. | 247.55M | -3.38% | 726,508 | 5.74M |
| 289 | RNAC | Cartesian Therapeutics, Inc. | 244.75M | -4.03% | 126,076 | 1.78M |
| 290 | SRZN | Surrozen, Inc. | 240.92M | -4.77% | 170,947 | 7.49M |
| 291 | ADAG | Adagene Inc. | 236.54M | -2.45% | 86,875 | 7.67M |
| 292 | PRQR | ProQR Therapeutics N.V. | 235.67M | -5.65% | 601,845 | 15.73M |
| 293 | FULC | Fulcrum Therapeutics, Inc. | 233.22M | -1.69% | 2,724,689 | 80.00M |
| 294 | IVVD | Invivyd, Inc. | 232.12M | -3.56% | 2,833,613 | 55.87M |
| 295 | TARA | Protara Therapeutics, Inc. | 229.31M | -0.97% | 354,985 | - |
| 296 | OBIO | Orchestra BioMed Holdings, Inc. | 222.76M | 1.92% | 186,891 | 32.72M |
| 297 | CGEN | Compugen Ltd. | 220.38M | -1.27% | 398,324 | 72.66M |
| 298 | AVXL | Anavex Life Sciences Corp. | 216.85M | -6.40% | 763,694 | - |
| 299 | ACIU | AC Immune SA | 216.26M | -7.63% | 238,884 | 4.62M |
| 300 | DTIL | Precision BioSciences, Inc. | 214.67M | -5.56% | 443,589 | 45.07M |
| 301 | CHRS | Coherus Oncology, Inc. | 214.41M | -3.47% | 608,903 | 46.88M |
| 302 | KPTI | Karyopharm Therapeutics Inc. | 212.58M | -1.57% | 236,381 | 151.12M |
| 303 | KROS | Keros Therapeutics, Inc. | 209.99M | -3.81% | 251,585 | 33.18M |
| 304 | WHWK | Whitehawk Therapeutics, Inc. | 209.22M | 1.04% | 529,086 | 7.15M |
| 305 | NAUT | Nautilus Biotechnology, Inc. | 208.41M | -5.75% | 532,831 | - |
| 306 | AGEN | Agenus Inc. | 208.21M | -0.20% | 2,696,460 | 123.87M |
| 307 | RNA | Atrium Therapeutics, Inc. | 208.00M | -1.14% | 182,681 | 36.68M |
| 308 | NBP | NovaBridge Biosciences | 207.01M | -3.24% | 263,942 | - |
| 309 | IMUX | Immunic, Inc. | 204.73M | -0.46% | 218,965 | - |
| 310 | CAMP | Camp4 Therapeutics Corporation | 202.51M | -7.36% | 165,642 | 3.93M |
| 311 | CLLS | Cellectis S.A. | 196.52M | -4.98% | 48,084 | 75.11M |
| 312 | CDXS | Codexis, Inc. | 196.34M | -2.26% | 393,916 | 78.09M |
| 313 | NERV | Minerva Neurosciences, Inc. | 196.14M | -2.55% | 166,346 | - |
| 314 | TNXP | Tonix Pharmaceuticals Holding Corp. | 188.90M | 2.07% | 420,530 | 17.56M |
| 315 | MDWD | MediWound Ltd. | 187.77M | 3.03% | 94,613 | 14.48M |
| 316 | PLX | Protalix BioTherapeutics, Inc. | 186.12M | -0.86% | 561,378 | 76.38M |
| 317 | NKTX | Nkarta, Inc. | 186.02M | -2.26% | 470,667 | - |
| 318 | VYGR | Voyager Therapeutics, Inc. | 183.68M | -5.00% | 683,767 | 36.49M |
| 319 | ACOG | Alpha Cognition Inc. | 181.81M | 0.60% | 38,990 | 10.83M |
| 320 | TNYA | Tenaya Therapeutics, Inc. | 181.76M | -0.66% | 2,379,085 | 225.00K |
| 321 | CNTN | Canton Strategic Holdings, Inc. | 180.47M | -2.09% | 784,774 | - |
| 322 | HUMA | Humacyte, Inc. | 177.85M | -3.23% | 8,426,880 | 2.02M |
| 323 | NRXP | NRx Pharmaceuticals, Inc. | 177.70M | -4.93% | 667,759 | 2.29M |
| 324 | NGEN | NervGen Pharma Corp. | 177.36M | -1.18% | 1,473,500 | - |
| 325 | KRRO | Korro Bio, Inc. | 177.11M | -5.76% | 197,985 | 3.84M |
| 326 | OTLK | Outlook Therapeutics, Inc. | 176.46M | -6.41% | 6,686,504 | 333.14K |
| 327 | ARCT | Arcturus Therapeutics Holdings Inc. | 175.65M | -3.29% | 708,105 | 54.71M |
| 328 | YDES | YD Bio Limited | 172.99M | 8.37% | 40,458 | 510.36K |
| 329 | MENS | Jyong Biotech Ltd. | 170.74M | 0.44% | 47,148 | - |
| 330 | MIST | Milestone Pharmaceuticals Inc. | 168.70M | -2.36% | 755,490 | 1.78M |
| 331 | ANTX | AN2 Therapeutics, Inc. | 168.20M | - | 86,011 | - |
| 332 | IPHA | Innate Pharma S.A. | 167.46M | -1.39% | 5,087 | 10.57M |
| 333 | ORMP | Oramed Pharmaceuticals Inc. | 165.75M | -0.25% | 144,470 | 2.00M |
| 334 | OKUR | OnKure Therapeutics, Inc. | 165.62M | -2.61% | 112,860 | - |
| 335 | CRBU | Caribou Biosciences, Inc. | 164.64M | -4.05% | 1,843,194 | 11.20M |
| 336 | ALEC | Alector, Inc. | 163.21M | -2.00% | 713,580 | 18.42M |
| 337 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 163.04M | -2.33% | 228,864 | - |
| 338 | EQ | Equillium, Inc. | 158.07M | -4.58% | 381,474 | 4.39M |
| 339 | ABOS | Acumen Pharmaceuticals, Inc. | 156.73M | -2.25% | 702,017 | - |
| 340 | PEPG | PepGen Inc. | 155.63M | -6.25% | 993,917 | - |
| 341 | LENZ | LENZ Therapeutics, Inc. | 153.01M | -2.20% | 1,943,256 | 20.99M |
| 342 | MOLN | Molecular Partners AG | 150.35M | 4.86% | 824 | 856.30K |
| 343 | KZIA | Kazia Therapeutics Limited | 149.92M | -2.38% | 140,947 | 1.27M |
| 344 | CNTB | Connect Biopharma Holdings Limited | 147.02M | -3.91% | 278,328 | 233.00K |
| 345 | TLSA | Tiziana Life Sciences Ltd | 142.24M | -0.90% | 225,284 | - |
| 346 | HURA | TuHURA Biosciences, Inc. | 141.38M | -2.63% | 491,558 | - |
| 347 | PYXS | Pyxis Oncology, Inc. | 141.28M | -8.23% | 414,399 | 13.86M |
| 348 | UNCY | Unicycive Therapeutics, Inc. | 138.33M | 0.60% | 858,424 | - |
| 349 | CBUS | Cibus, Inc. | 138.16M | -12.98% | 351,036 | 4.29M |
| 350 | AARD | Aardvark Therapeutics, Inc. | 138.10M | -5.10% | 146,774 | - |
| 351 | ARMP | Armata Pharmaceuticals, Inc. | 138.03M | -5.76% | 342,673 | 5.20M |
| 352 | GUTS | Fractyl Health, Inc. | 135.53M | -6.12% | 2,661,495 | 3.00K |
| 353 | ENGN | enGene Therapeutics Inc. | 128.62M | 1.05% | 756,761 | - |
| 354 | GNLX | Genelux Corporation | 125.23M | -3.09% | 185,460 | 8.00K |
| 355 | SPRB | Spruce Biosciences, Inc. | 121.87M | -2.55% | 86,797 | 697.00K |
| 356 | PMN | ProMIS Neurosciences, Inc. | 119.27M | -5.07% | 163,105 | - |
| 357 | SEER | Seer, Inc. | 118.76M | - | 202,167 | 15.17M |
| 358 | CUE | Cue Biopharma, Inc. | 116.73M | -2.46% | 193,105 | 32.73M |
| 359 | VANI | Vivani Medical, Inc. | 116.42M | -4.26% | 650,875 | - |
| 360 | FBIO | Fortress Biotech, Inc. | 113.61M | -7.82% | 763,180 | 66.16M |
| 361 | ANIX | Anixa Biosciences, Inc. | 112.96M | -5.14% | 258,324 | - |
| 362 | KLRS | Kalaris Therapeutics, Inc. | 109.68M | -4.36% | 61,346 | - |
| 363 | PLYX | Polaryx Therapeutics, Inc. | 109.36M | -4.15% | 44,330 | - |
| 364 | COYA | Coya Therapeutics, Inc. | 107.90M | -4.96% | 343,766 | 7.94M |
| 365 | ONCY | Oncolytics Biotech Inc. | 105.40M | -2.31% | 833,101 | - |
| 366 | ALDX | Aldeyra Therapeutics, Inc. | 103.75M | -10.42% | 2,597,198 | - |
| 367 | BDTX | Black Diamond Therapeutics, Inc. | 103.72M | - | 855,858 | 70.00M |
| 368 | ICCC | ImmuCell Corporation | 100.69M | 3.73% | 48,344 | 29.93M |
| 369 | PYPD | PolyPid Ltd. | 99.51M | -0.38% | 188,931 | - |
| 370 | ENTX | Entera Bio Ltd. | 98.58M | 12.36% | 577,519 | 42.00K |
| 371 | VRCA | Verrica Pharmaceuticals Inc. | 95.51M | -1.77% | 23,633 | 37.16M |
| 372 | PTHS | Pelthos Therapeutics Inc. | 92.83M | -1.80% | 17,907 | 27.70M |
| 373 | INO | Inovio Pharmaceuticals, Inc. | 92.15M | -4.27% | 1,076,154 | 65.34K |
| 374 | BMEA | Biomea Fusion, Inc. | 91.10M | -2.33% | 552,942 | - |
| 375 | SPRO | Spero Therapeutics, Inc. | 90.91M | -7.65% | 2,627,726 | 61.19M |
| 376 | HRTX | Heron Therapeutics, Inc. | 90.10M | 8.43% | 5,543,338 | 150.71M |
| 377 | ATHE | Alterity Therapeutics Limited | 89.85M | 1.90% | 12,598 | 4.43M |
| 378 | ACET | Adicet Bio, Inc. | 86.32M | -5.30% | 113,892 | - |
| 379 | RLYB | Rallybio Corporation | 84.56M | -1.05% | 53,316 | 858.00K |
| 380 | NTHI | NeOnc Technologies Holdings, Inc. | 84.28M | -8.19% | 112,946 | 39.99K |
| 381 | CGTX | Cognition Therapeutics, Inc. | 84.13M | -0.96% | 787,808 | - |
| 382 | NRXS | NeurAxis, Inc. | 83.97M | -2.87% | 146,838 | 4.28M |
| 383 | GOSS | Gossamer Bio, Inc. | 83.35M | 5.44% | 14,222,454 | 55.54M |
| 384 | RANI | Rani Therapeutics Holdings, Inc. | 82.99M | -1.05% | 857,371 | 3.17M |
| 385 | TELO | Telomir Pharmaceuticals, Inc. | 81.84M | -1.65% | 60,086 | - |
| 386 | CSBR | Champions Oncology, Inc. | 81.10M | 1.04% | 5,438 | 57.95M |
| 387 | MAIA | MAIA Biotechnology, Inc. | 80.87M | -9.52% | 1,003,188 | - |
| 388 | RNTX | Rein Therapeutics Inc. | 80.20M | -8.90% | 203,618 | - |
| 389 | ATRA | Atara Biotherapeutics, Inc. | 78.57M | 1.99% | 40,116 | 23.14M |
| 390 | ENLV | Enlivex Ltd. | 76.33M | -18.66% | 224,764 | - |
| 391 | ACRV | Acrivon Therapeutics, Inc. | 74.90M | -8.85% | 547,930 | - |
| 392 | ALPS | Alps Group Inc | 74.05M | -6.90% | 60,939 | 3.74M |
| 393 | ANVS | Annovis Bio, Inc. | 74.02M | -3.33% | 475,805 | - |
| 394 | LONA | LeonaBio, Inc. | 73.36M | -8.44% | 55,434 | - |
| 395 | OKYO | OKYO Pharma Limited | 72.42M | -7.38% | 207,437 | - |
| 396 | GANX | Gain Therapeutics, Inc. | 70.81M | -1.19% | 845,830 | - |
| 397 | HYFT | MindWalk Holdings Corp. | 70.03M | -5.37% | 211,144 | 20.70M |
| 398 | MNOV | MediciNova, Inc. | 69.89M | 1.43% | 61,626 | 596.64K |
| 399 | XBIT | XBiotech Inc. | 69.82M | - | 21,908 | - |
| 400 | PMVP | PMV Pharmaceuticals, Inc. | 69.33M | -7.14% | 217,450 | - |
| 401 | PLRX | Pliant Therapeutics, Inc. | 68.21M | -0.89% | 532,676 | - |
| 402 | IBIO | iBio, Inc. | 67.07M | -5.59% | 1,469,633 | 300.00K |
| 403 | OSTX | OS Therapies Incorporated | 66.81M | -3.23% | 682,346 | - |
| 404 | IMA | ImageneBio, Inc. | 61.47M | -9.32% | 31,181 | 800.00K |
| 405 | ELTX | Elicio Therapeutics, Inc. | 61.03M | 5.26% | 561,915 | - |
| 406 | CRDF | Cardiff Oncology, Inc. | 59.79M | -1.66% | 3,015,961 | 525.00K |
| 407 | EDSA | Edesa Biotech, Inc. | 59.75M | -2.18% | 56,671 | - |
| 408 | CING | Cingulate Inc. | 59.67M | -3.49% | 323,232 | - |
| 409 | TCRX | TScan Therapeutics, Inc. | 58.72M | -2.65% | 651,704 | 9.14M |
| 410 | CNTX | Context Therapeutics Inc. | 56.47M | -2.49% | 1,371,525 | - |
| 411 | BOLD | Boundless Bio, Inc. | 55.93M | 0.81% | 137,751 | - |
| 412 | IMMP | Immutep Limited | 55.72M | -0.25% | 200,815 | 5.28M |
| 413 | INMB | INmune Bio Inc. | 55.03M | - | 557,816 | 50.00K |
| 414 | XLO | Xilio Therapeutics, Inc. | 54.03M | -0.99% | 115,872 | 53.48M |
| 415 | INKT | MiNK Therapeutics, Inc. | 53.85M | -2.52% | 9,294 | - |
| 416 | EXOZ | eXoZymes, Inc. | 52.74M | 1.63% | 10,463 | -700.00 |
| 417 | BYSI | BeyondSpring Inc. | 52.63M | 0.79% | 43,896 | 1.88M |
| 418 | FLNA | Filana Therapeutics, Inc. | 52.17M | -1.82% | 399,511 | - |
| 419 | VRXA | Veraxa Biotech AG | 51.70M | -3.30% | 114,679 | - |
| 420 | MREO | Mereo BioPharma Group plc | 51.52M | -1.56% | 882,362 | 500.00K |
| 421 | APLM | Apollomics, Inc. | 51.10M | 21.26% | 66,574 | 8.84M |
| 422 | TIL | Instil Bio, Inc. | 50.93M | -1.44% | 9,935 | - |
| 423 | ATYR | aTyr Pharma, Inc. | 50.58M | -3.44% | 1,371,420 | 190.00K |
| 424 | MCRB | Seres Therapeutics, Inc. | 50.16M | -4.95% | 84,139 | 1.15M |
| 425 | IBO | Impact BioMedical Inc. | 49.17M | -0.87% | 81,557 | 39.00K |
| 426 | ELOX | Eloxx Pharmaceuticals, Inc. | 48.52M | -4.53% | 48,928 | - |
| 427 | RADX | Radiopharm Theranostics Limited | 47.15M | -0.92% | 19,761 | 10.86M |
| 428 | MGX | Metagenomi Therapeutics, Inc. | 46.68M | -3.88% | 163,911 | 22.33M |
| 429 | DWTX | Dogwood Therapeutics, Inc. | 46.07M | -4.86% | 70,896 | - |
| 430 | DYAI | Dyadic International, Inc. | 43.36M | -2.46% | 104,750 | 3.81M |
| 431 | CRVO | CervoMed Inc. | 42.47M | 2.28% | 464,306 | 2.09M |
| 432 | HYPD | Hyperion DeFi, Inc. | 41.68M | -8.94% | 252,144 | 1.04M |
| 433 | NNVC | NanoViricides, Inc. | 40.32M | 2.91% | 607,975 | - |
| 434 | RNXT | RenovoRx, Inc. | 39.73M | 2.49% | 206,298 | 1.49M |
| 435 | ACTU | Actuate Therapeutics, Inc. | 39.72M | -3.49% | 172,512 | - |
| 436 | PDSB | PDS Biotechnology Corporation | 39.70M | -4.66% | 159,281 | - |
| 437 | GRCE | Grace Therapeutics, Inc. | 39.22M | -0.82% | 279,802 | - |
| 438 | NTRB | Nutriband Inc. | 38.05M | 2.62% | 23,683 | 1.80M |
| 439 | VERU | Veru Inc. | 37.72M | -2.89% | 247,364 | 16.89M |
| 440 | LTRN | Lantern Pharma Inc. | 37.13M | -6.13% | 265,840 | - |
| 441 | ALGS | Aligos Therapeutics, Inc. | 35.58M | -0.35% | 54,757 | 4.71M |
| 442 | GNTA | Genenta Science S.p.A. | 33.97M | -4.00% | 92,670 | - |
| 443 | BCTX | BriaCell Therapeutics Corp. | 33.09M | -2.28% | 164,779 | - |
| 444 | LITS | Lite Strategy, Inc. | 33.01M | -1.91% | 138,718 | - |
| 445 | ESLA | Estrella Immunopharma, Inc. | 31.94M | -3.84% | 11,011 | - |
| 446 | LSTA | Lisata Therapeutics, Inc. | 31.87M | -6.67% | 134,924 | 170.00K |
| 447 | ABVC | ABVC BioPharma, Inc. | 30.58M | -5.47% | 126,877 | 797.92K |
| 448 | KYNB | Kyntra Bio, Inc. | 29.92M | 2.50% | 10,226 | 7.44M |
| 449 | SER | Serina Therapeutics, Inc. | 29.70M | 1.54% | 31,261 | 130.00K |
| 450 | DARE | Daré Bioscience, Inc. | 29.06M | -6.28% | 198,231 | 1.16M |
| 451 | TVRD | Tvardi Therapeutics, Inc. | 28.89M | 5.12% | 1,716,857 | - |
| 452 | ATNM | Actinium Pharmaceuticals, Inc. | 27.92M | -3.25% | 64,837 | 90.00K |
| 453 | BRNS | Barinthus Biotherapeutics plc | 27.37M | 2.34% | 6,042 | 14.97M |
| 454 | PSTV | Plus Therapeutics, Inc. | 26.84M | -4.41% | 81,585 | 5.18M |
| 455 | EVAX | Evaxion A/S | 26.02M | 2.30% | 16,881 | 7.53M |
| 456 | IGC | IGC Pharma, Inc. | 25.65M | -4.33% | 445,354 | 1.11M |
| 457 | VYNE | VYNE Therapeutics Inc. | 25.60M | 1.36% | 1,537,292 | 454.00K |
| 458 | GRDX | GridAI Technologies Corp. | 25.35M | -5.93% | 11,490 | - |
| 459 | NRSN | NeuroSense Therapeutics Ltd. | 24.83M | -2.31% | 70,247 | - |
| 460 | PLRZ | Polyrizon Ltd. | 24.33M | -0.54% | 11,144 | - |
| 461 | MRKR | Marker Therapeutics, Inc. | 22.34M | -4.96% | 69,079 | 3.55M |
| 462 | NXTC | NextCure, Inc. | 22.29M | -6.94% | 4,232,438 | - |
| 463 | CELU | Celularity Inc. | 22.23M | -1.53% | 39,435 | 26.55M |
| 464 | SKYE | Skye Bioscience, Inc. | 22.09M | 3.71% | 54,587 | - |
| 465 | JSPR | Jasper Therapeutics, Inc. | 21.67M | 11.85% | 16,994,889 | - |
| 466 | QNTM | Quantum BioPharma Ltd. | 21.65M | -0.88% | 63,534 | - |
| 467 | NCEL | NewcelX Ltd. | 21.05M | -0.51% | 19,852 | - |
| 468 | CLRB | Cellectar Biosciences, Inc. | 20.62M | -1.15% | 45,925 | - |
| 469 | ATOS | Atossa Therapeutics, Inc. | 20.58M | -2.05% | 68,961 | - |
| 470 | AKTX | Akari Therapeutics, Plc | 20.13M | -4.72% | 35,962 | - |
| 471 | CVM | CEL-SCI Corporation | 20.10M | - | 1,578,104 | - |
| 472 | PLUR | Pluri Inc. | 19.42M | 2.86% | 77,594 | 1.08M |
| 473 | LGVN | Longeveron Inc. | 19.38M | -3.45% | 86,741 | 1.22M |
| 474 | NEUP | Neuphoria Therapeutics Inc. | 19.08M | 0.28% | 16,274 | -13.27K |
| 475 | LPCN | Lipocine Inc. | 18.88M | -2.97% | 30,358 | 2.00M |
| 476 | ALLR | Allarity Therapeutics, Inc. | 18.62M | -0.85% | 102,638 | 345.00K |
| 477 | TVGN | Tevogen Bio Holdings Inc. | 18.47M | -7.74% | 19,863 | - |
| 478 | QNCX | Quince Therapeutics, Inc. | 18.26M | 0.48% | 61,735 | - |
| 479 | HOWL | Werewolf Therapeutics, Inc. | 17.88M | 8.37% | 389,400 | 1.14M |
| 480 | PTN | Palatin Technologies, Inc. | 17.12M | -4.78% | 11,593 | 12.88M |
| 481 | OSRH | OSR Health, Inc. | 17.05M | 15.51% | 2,483,367 | 2.63M |
| 482 | ICU | SeaStar Medical Holding Corporation | 16.97M | -8.66% | 88,114 | 1.44M |
| 483 | PASG | Passage Bio, Inc. | 15.75M | - | 76,041 | - |
| 484 | KALA | KALA BIO, Inc. | 15.75M | -17.76% | 247,755 | - |
| 485 | CYCN | Cyclerion Therapeutics, Inc. | 15.52M | -1.35% | 11,443 | 1.99M |
| 486 | HIND | Vyome Holdings, Inc. | 15.37M | -3.52% | 6,650 | 152.72K |
| 487 | KTTA | Pasithea Therapeutics Corp. | 15.28M | -4.35% | 293,582 | - |
| 488 | MLEC | Moolec Science SA | 14.56M | -1.69% | 1,326 | 7.83M |
| 489 | TPST | Tempest Therapeutics, Inc. | 14.45M | -8.77% | 121,297 | - |
| 490 | SNTI | Senti Biosciences Holdings, Inc. | 14.32M | -21.19% | 1,359,156 | 38.00K |
| 491 | CTXR | Citius Pharmaceuticals, Inc. | 14.01M | -3.88% | 210,189 | 5.61M |
| 492 | LEXX | Lexaria Bioscience Corp. | 13.87M | -4.88% | 182,815 | 194.00K |
| 493 | GTBP | GT Biopharma, Inc. | 13.83M | 9.45% | 745,387 | - |
| 494 | INAB | IN8bio, Inc. | 13.59M | -4.17% | 105,007 | - |
| 495 | INTS | Intensity Therapeutics, Inc. | 13.24M | 1.24% | 17,516 | - |
| 496 | COCP | Cocrystal Pharma, Inc. | 13.10M | -1.03% | 7,680 | 225.00K |
| 497 | LNAI | Lunai Bioworks Inc. | 13.06M | -3.36% | 62,794 | 20.94K |
| 498 | BLRX | BioLineRx Ltd. | 13.02M | 2.41% | 7,371 | 1.40M |
| 499 | BIVI | BioVie Inc. | 12.97M | -2.82% | 73,044 | - |
| 500 | GDTC | CytoMed Therapeutics Limited | 12.07M | - | 2,641 | 669.28K |